Ardelyx, Inc. (ARDX) is a publicly traded Healthcare sector company. As of July 17, 2026, ARDX trades at $5.20 with a market cap of $1.27B and a P/E ratio of -20.06. ARDX moved +1.46% today. Year to date, ARDX is -10.81%; over the trailing twelve months it is +15.04%. Its 52-week range spans $3.21 to $8.40. Analyst consensus is strong buy with an average price target of $16.17. Rallies surfaces ARDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
6 analysts cover ARDX: 0 strong buy, 6 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $16.17.
| Metric | Value |
|---|---|
| Price | $5.20 |
| Market Cap | $1.27B |
| P/E Ratio | -20.06 |
| EPS | $-0.26 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.40 |
| 52-Week Low | $3.21 |
| Volume | 2.90M |
| Avg Volume | 0 |
| Revenue (TTM) | $407.32M |
| Net Income | $-61.60M |
| Gross Margin | 90.29% |
6 analysts cover ARDX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.17.